Your browser doesn't support javascript.
loading
HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure.
Trieb, Markus; Rainer, Florian; Stadlbauer, Vanessa; Douschan, Philipp; Horvath, Angela; Binder, Lukas; Trakaki, Athina; Knuplez, Eva; Scharnagl, Hubert; Stojakovic, Tatjana; Heinemann, Ákos; Mandorfer, Mattias; Paternostro, Rafael; Reiberger, Thomas; Pitarch, Carla; Amorós, Alex; Gerbes, Alexander; Caraceni, Paolo; Alessandria, Carlo; Moreau, Richard; Clària, Joan; Marsche, Gunther; Stauber, Rudolf E.
Afiliación
  • Trieb M; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria.
  • Rainer F; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Stadlbauer V; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Douschan P; Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Horvath A; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Center for Biomarker Research in Medicine (CBmed), Graz, Austria.
  • Binder L; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Trakaki A; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
  • Knuplez E; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
  • Scharnagl H; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Stojakovic T; Clinical Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Graz, Graz, Austria.
  • Heinemann Á; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.
  • Mandorfer M; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
  • Paternostro R; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
  • Reiberger T; Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria.
  • Pitarch C; European Foundation for the Study of Chronic Liver Failure (EF Clif), Barcelona, Spain.
  • Amorós A; European Foundation for the Study of Chronic Liver Failure (EF Clif), Barcelona, Spain.
  • Gerbes A; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.
  • Caraceni P; European Foundation for the Study of Chronic Liver Failure (EF Clif), Barcelona, Spain; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Alessandria C; European Foundation for the Study of Chronic Liver Failure (EF Clif), Barcelona, Spain; Division of Gastroenterology and Hepatology, Città della Salute e della Scienza Hospital, University of Turin, Turin, Italy.
  • Moreau R; European Foundation for the Study of Chronic Liver Failure (EF Clif), Barcelona, Spain; Institut national de la Santé et de la Recherche Médicale, Université de Paris, Centre de Recherche sur l'Inflammation, Paris et Service d'hépatologie, Hôpital Beaujon, APHP, Clichy, France.
  • Clària J; European Foundation for the Study of Chronic Liver Failure (EF Clif), Barcelona, Spain; Hospital Clínic, IDIBAPS and CIBERehd, Barcelona, Spain.
  • Marsche G; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria. Electronic address: gunther.marsche@medunigraz.at.
  • Stauber RE; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Electronic address: rudolf.stauber@medunigraz.at.
J Hepatol ; 73(1): 113-120, 2020 07.
Article en En | MEDLINE | ID: mdl-32061870
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Apolipoproteína A-I / Lipoproteínas HDL2 / Lipoproteínas HDL3 / Insuficiencia Hepática Crónica Agudizada / HDL-Colesterol / Cirrosis Hepática Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Apolipoproteína A-I / Lipoproteínas HDL2 / Lipoproteínas HDL3 / Insuficiencia Hepática Crónica Agudizada / HDL-Colesterol / Cirrosis Hepática Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Austria